Nature Communications, 2024
A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and naïve non-human primates

Vijayan A., Vogels R., Groppo R. et al.

Metabolic Brain Disease, 2024
Individuals with SATB2-associated syndrome have impaired vitamin and energy metabolism pathways

Collu R., Zarate Y., Xia W. et al.

Transfusion and Apheresis Science, 2024
Mechanistic insights from a pilot exploratory study of the dynamic proteomic changes during plasma exchange in patients with acute liver failure

Jauniaux B., Burke L., Snook N. et al.

Circulation, 2024
A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia

Ho F., Mark P., Lees J. et al.

Frontiers in Immunology, 2024
A targeted proteomics screen reveals serum and synovial fluid proteomic signature in patients with gout

Huang Z., Zhong X., Zhang Y. et al.

Neurology Neuroimmunology & Neuroinflammation, 2024
Proteomics Reveals Age as Major Modifier of Inflammatory CSF Signatures in Multiple Sclerosis

Held F., Makarov C., Gasperi C. et al.

Science Translational Medicine, 2024
Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution

Hamlin R., Pienkos S., Chan L. et al.

GeroScience, 2024
Plasma proteomic signature of risk and prognosis of frailty in the UK Biobank

Xu J., Liu J., Tang J. et al.

Journal of Leukocyte Biology, 2024
Interleukin-10 inhibits important components of trained immunity in human monocytes

Röring R., Scognamiglio F., de Jong L. et al.

Journal of Stroke and Cerebrovascular Diseases, 2024
Sodium-glucose cotransporter protein 2 inhibition, plasma proteins, and ischemic stroke: A mediation Mendelian randomization and colocalization study

Chen Z., Meng H., Guo Y. et al.

GeroScience, 2024
Plasma proteomics-based brain aging signature and incident dementia risk

Kou M., Ma H., Wang X. et al.

EPMA Journal, 2024
Mendelian randomization reveals predictive, preventive, and personalized insights into inflammatory bowel disease: the role of gut microbiome and circulating inflammatory proteins

Zhao W., Li S., Li Q. et al.

British Journal of Nutrition, 2024
The protective effect of higher serum triacylglycerol (51:4) levels against Parkinson’s disease

Jing Y., Su J., Zhu H. et al.

BJPsych Open, 2024
Depression in childhood to early adulthood and respiratory health in early adulthood

Wang G., Hallberg J., Hernandez-Pacheco N. et al.

Frontiers in Molecular Biosciences, 2024
Proteomics analysis of extracellular vesicles for biomarkers of autism spectrum disorder

Ali Moussa H., Shin K., de la Fuente A. et al.

Molecular Neurodegeneration, 2024
CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals

del Campo M., Quesada C., Vermunt L. et al.

Journal of the Neurological Sciences, 2024
Multi-Omic characterization of the effects of Ocrelizumab in patients with relapsing-remitting multiple sclerosis

Kornilov S., Price N., Gelinas R. et al.

Journal of Translational Medicine, 2024
Shedding of membrane complement inhibitors CD59 and CD46 into the circulation is associated with poor prognosis in acute coronary syndrome patients: a cohort study

Zhong B., King B., Waziri H. et al.

Nature Medicine, 2024
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial

Li R., Villa N., Yu X. et al.

Nature Communications, 2024
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker

Martins T., Kaymak D., Tatari N. et al.